To produce PLPs, bacteria must contain both a helper phage (like M13KO7), that codes for the different phage proteins, and also a phagemid, that encodes the toxic gene we want to include in the PLP. If M13KO7 is packaged a replicative phage is produced, which we do not want, and if the phagemid it packaged then a PLP is produced.

The problem

Our objective is to produce phage like particles (PLP), for this, the bacteria must contain both a helper phage and also a phagemid (Figure 1). During phage production, several key events determine which DNA molecules are packaged into phage or PLP. These involve recognition of the M13 replication origin by several phage proteins.

A major hurdle to marketing KILL XYL is obtaining the necessary authorizations. Our interviews and legislation study both showed that the number of viable phages could be a problem. We therefore decided to measure and model the ratio between viable phage and phage-like particles, and so try to optimize this ratio to facilitate the preparation of pure PLP.

The Model

We based our model on a recently published model of "wild-type" M13 replication ^{[1] [2]}.

This model was modified to accomodate the fact our system has two plasmids (Helper and Phagemid) when Smeal's has only one. This means we incorporated: the presence of a phagemid, with its own replicative origin and M13 origin, the helper-phage E. coli plasmid origin and the modification of the helper-phage M13 origin. This was done either through adapting pre-existing species, parameters and equations, or creating new ones. These modifications added 9 species and 3 parameters to the original model, and changed 5 other pre-existing species and 3 other pre-existing parameters. 13 new equations were created.

The modified model is available File:T--Aix-Marseille--Model.zip

We used the initial measurement to constrain parameters of the model, along with published numbers for the number of copies of plasmids with different replicative origins.

Results

The packaging ratio depends on two main parameters: the initial ratio of transfected phagemid and helper phage (Figure 2), and the difference in p5 affinity for eitheir plasmid's M13 ori (Figure 3). We also observed increasing the number of transfected plasmids increased production, up to a certain point, which we determined (Figure 4).

Figure2: Scan for the optimal initial ratio of transfected helper phage and phagemid. We simulated the final PLP/RP ratio for initial quantities of transfected helper phage and phagemid varying from 1 to 10 each (100 data points). The trend line represents a power law.

Figure3: Scan for the M13 to P5 affinity optimizing production ratio of phage-like particle to replicating phage. This parameters is diminished in our engineered M13 origin of replication as compared to the wild-type origin of replication. We simulated the final PLP/RP ratio for M13 to p5 affinity varying from 1/100th to 10 times it's physiological parameters. M13's affinity for p5 is expressed as a percentage of the physiological parameter.

Our optimal cell factory will have 3 transfected phagemids and 1 helper phage. This can be controled by adjusting the quantity of DNA added in the transfection chamber.

Conclusions

Clearly the initial design needs to be improved to increase the proportion of PLP produced.

1. ↑ Smeal et al, Simulation of the M13 life cycle I: Assembly of a genetically-structured deterministic chemical kinetic simulation, Virology, 500, January 2017
2. ↑ Smeal et al, Simulation of the M13 life cycle II: Investigation of the control mechanisms of M13 infection and establishment of the carrier state, Virology, 500, January 2017